tiprankstipranks
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
US Market
ADPT
Adaptive Biotechnologies
RESEARCH TOOLSreports
Want to see ADPT full AI Analyst Report?

Adaptive Biotechnologies (ADPT) Income Statement

1,026 Followers

Adaptive Biotechnologies Income Statement

Last quarter (Q4 2025), Adaptive Biotechnologies's total revenue was $71.68M, an increase of 51.04% from the same quarter last year. In Q4, Adaptive Biotechnologies's net income was $-13.58M. See Adaptive Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 276.98M$ 178.96M$ 170.28M$ 185.31M$ 154.34M
Gross Profit
$ 205.62M$ 106.88M$ 94.72M$ 127.40M$ 105.04M
Operating Expenses
$ 262.74M$ 269.43M$ 321.76M$ 327.58M$ 314.01M
Depreciation and Amortization
$ 17.83M$ 19.26M$ 22.23M$ 20.92M$ 13.95M
EBITDA
$ -29.85M$ -128.76M$ -189.27M$ -175.21M$ -193.34M
Operating Income
$ -57.12M$ -162.55M$ -227.03M$ -200.19M$ -208.97M
Other Income/Expenses
$ -2.33M$ 2.95M$ 1.73M$ -182.00K$ 1.67M
Pretax Income
$ -59.46M$ -159.59M$ -225.30M$ -200.37M$ -207.30M
Net Income
$ -59.50M$ -159.49M$ -225.25M$ -200.19M$ -207.28M
Per Share Metrics
Basic EPS
$ -0.39$ -1.08$ -1.56$ -1.00$ -1.46
Diluted EPS
$ -0.39$ -1.08$ -1.56$ -1.00$ -1.46
Weighted Average Shares Outstanding
 151.72M 147.10M 144.38M 142.52M 140.35M
Weighted Average Shares Outstanding (Diluted)
 151.72M 147.10M 144.38M 142.52M 140.35M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History